1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.

https://doi.org/10.1016/S0092-8674(00)81683-9

PMid:10647931

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-49.

https://doi.org/10.3322/caac.21660

PMid:33538338 

3. Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20:769-80.

https://doi.org/10.1016/S1470-2045(19)30163-9

PMid:31078462

4. Bashraheel SS, Domling A, Goda SK. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomed Pharmacother. 2020;125:110009.

https://doi.org/10.1016/j.biopha.2020.110009

PMid:32106381 

5. Sonis ST. New thoughts on the initiation of mucositis. Oral Dis. 2010;16:597-600.

https://doi.org/10.1111/j.1601-0825.2010.01681.x

PMid:20846150 

6. Peterson DE, Srivastava R, Lalla RV. Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Dis. 2015;21:133-41.

https://doi.org/10.1111/odi.12167

PMid:24131518 

7. Basile D, Di Nardo P, Corvaja C, Garattini SK, Pelizzari G, Lisanti C, et al. Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside. Cancers (Basel). 2019;11:857.

https://doi.org/10.3390/cancers11060857

PMid:31226812 PMCid:PMC6627284

8. Marcussen M, Sønderkær M, Bødker JS, Andersen M, Nielsen S, Vesteghem C, et al. Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma. PLoS One. 2018;13:e0190709.

https://doi.org/10.1371/journal.pone.0190709

PMid:29338018 PMCid:PMC5770028

9. Villa A, Sonis ST. An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis. Expert Opin Pharmacother. 2020;21:541-8.

https://doi.org/10.1080/14656566.2020.1718652

PMid:31990597 

10. Pels EJ. Oral mucositis and saliva IgA, IgG and IgM concentration during anti-tumor treatment in children suffering from acute lymphoblastic leukemia. Adv Clin Exp Med. 2017;26:1351-8.

https://doi.org/10.17219/acem/64940

PMid:29442455 

11. Napeñas JJ, Brennan MT, Bahrani-Mougeot FK, Fox PC, Lockhart PB. Relationship between mucositis and changes in oral microflora during cancer chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:48-59.

https://doi.org/10.1016/j.tripleo.2005.12.016

PMid:17178494 

12. Mougeot JC, Stevens CB, Morton DS, Brennan MT, Mougeot FB. Oral Microbiome and Cancer Therapy-Induced Oral Mucositis. J Natl Cancer Inst Monogr. 2019;2019:lgz002.

PMid:31425594

13. Sharma N, Bhatia S, Sodhi AS, Batra N. Oral microbiome and health. AIMS Microbiol. 2018;4:42-66.

https://doi.org/10.3934/microbiol.2018.1.42

PMid:31294203 PMCid:PMC6605021

14. Bunetel L, Tamanai-Shacoori Z, Martin B, Autier B, Guiller A, Bonnaure-Mallet M. Interactions between oral commensal Candida and oral bacterial communities in immunocompromised and healthy children. J Mycol Med. 2019;29:223-32.

https://doi.org/10.1016/j.mycmed.2019.06.004

PMid:31235209 

15. Stringer AM, Logan RM. The role of oral flora in the development of chemotherapy-induced oral mucositis. J Oral Pathol Med. 2015;44:81-7.

https://doi.org/10.1111/jop.12152

PMid:24494824 

16. Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16:745-59.

https://doi.org/10.1038/s41579-018-0089-x

PMid:30301974 PMCid:PMC6278837

17. Boskey AL, Coleman R. Aging and bone. J Dent Res. 2010;89:1333-48.

https://doi.org/10.1177/0022034510377791

PMid:20924069 PMCid:PMC2991386

18. Vanhoecke B, De Ryck T, Stringer A, Van de Wiele T, Keefe D. Microbiota and their role in the pathogenesis of oral mucositis. Oral Dis. 2015;21:17-30.

https://doi.org/10.1111/odi.12224

PMid:24456144 

19. Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019;27:4023-33.

https://doi.org/10.1007/s00520-019-04893-z

PMid:31286231 

20. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71.

https://doi.org/10.1136/bmj.n71

PMid:33782057 PMCid:PMC8005924

21. Aslam S, Emmanuel P. Formulating a researchable question: A critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS. 2010;31:47-50.

https://doi.org/10.4103/0253-7184.69003

PMid:21808439 PMCid:PMC3140151

22. Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015;26:v139-51.

https://doi.org/10.1093/annonc/mdv202

PMid:26142468 

23. Mathes T, Pieper D. Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC Med Res Methodol. 2017;17:107.

https://doi.org/10.1186/s12874-017-0391-8

PMid:28716005 PMCid:PMC5513097

24. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.

https://doi.org/10.1007/s10654-010-9491-z

PMid:20652370 

25. Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7:66.

https://doi.org/10.1186/s40168-019-0679-5

PMid:31018870 PMCid:PMC6482518

26. Laheij AMGA, Raber-Durlacher JE, Koppelmans RGA, Huysmans MDNJM, Potting C, van Leeuwen SJM, et al. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019;9:16929.

https://doi.org/10.1038/s41598-019-53073-w

PMid:31729407 PMCid:PMC6858439

27. Robinson S, Peterson CB, Sahasrabhojane P, Ajami NJ, Shelburne SA, Kontoyiannis DP, et al. Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia. mSphere. 2020;5:e00048-20.

https://doi.org/10.1128/mSphere.00048-20

PMid:32295867 PMCid:PMC7160678

28. Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, et al. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients. Genome Med. 2017;9:21.

https://doi.org/10.1186/s13073-017-0409-1

PMid:28245856 PMCid:PMC5331640

29. Diaz PI, Hong BY, Dupuy AK, Choquette L, Thompson A, Salner AL, et al. Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy. J Fungi (Basel). 2019;5:49.

https://doi.org/10.3390/jof5020049

PMid:31200520 PMCid:PMC6617088

30. Reyes-Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, et al. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 2020;126:5124-36.

https://doi.org/10.1002/cncr.33161

PMid:32888342 PMCid:PMC8191575

31. Chen C, Zhang Q, Yu W, Chang B, Le AD. Oral Mucositis: An Update on Innate Immunity and New Interventional Targets. J Dent Res. 2020;99:1122-30.

https://doi.org/10.1177/0022034520925421

PMid:32479139 PMCid:PMC7443999

32. Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200:525-40.

https://doi.org/10.1007/s00203-018-1505-3

PMid:29572583 

33. Burcham ZM, Garneau NL, Comstock SS, Tucker RM, Knight R, Metcalf JL, et al. Patterns of Oral Microbiota Diversity in Adults and Children: A Crowdsourced Population Study. Sci Rep. 2020;10:2133.

https://doi.org/10.1038/s41598-020-59016-0

PMid:32034250 PMCid:PMC7005749

34. Lacouture M, Sibaud V. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails. Am J Clin Dermatol. 2018;19:31-9.

https://doi.org/10.1007/s40257-018-0384-3

PMid:30374901 PMCid:PMC6244569

35. Jo R, Nishimoto Y, Umezawa K, Yama K, Aita Y, Ichiba Y, et al. Comparison of oral microbiome profiles in stimulated and unstimulated saliva, tongue, and mouth-rinsed water. Sci Rep. 2019;9:16124.

https://doi.org/10.1038/s41598-019-52445-6

PMid:31695050 PMCid:PMC6834574

36. Caselli E, Fabbri C, D'Accolti M, Soffritti I, Bassi C, Mazzacane S, et al. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol. 2020;20:120.

https://doi.org/10.1186/s12866-020-01801-y

PMid:32423437 PMCid:PMC7236360